International Journal of Pharmaceutical Medicine

12th International Conference on Pharmaceutical Medicine, Cancun, Mexico, 5–8 May 2002
pp. 1-1(1)
Author: Snell N.

Changes at the IJPM
pp. 1-2(2)
Author: Snell N.

New rules on pharmacovigilance in Europe: more of the same?
pp. 3-4(2)
Author: Brown E.

Striking a balance: concerted action for children's medicines
pp. 5-6(2)
Authors: Crawley F.; Smith R.

Dr Robert N Smith – an appreciation
pp. 7-8(2)
Author: listed n.

How to increase trust in reporting pharmaceutical research findings
pp. 9-9(1)
Authors: Mark G.; Brian H.

Putting the child first: research as a part of paediatric care
pp. 11-13(3)
Author: R K.

A European Conference on Clinical Research in Children: ethical, scientific and regulatory issues
pp. 15-24(10)
Author: listed n.

A European Conference on Clinical Research in Children: ethical, scientific and regulatory issues
pp. 20-23(4)
Author: listed n.

A European Conference on Clinical Research in Children: ethical, scientific and regulatory issues
pp. 23-24(2)
Author: listed n.

none listed
pp. 25-29(5)
Author: listed n.

12th International Conference On Pharmaceutical Medicine: The Future is Now. Cancun, Mexico: 5-8 May 2002
pp. 31-33(3)
Author: listed n.

12th International Conference On Pharmaceutical Medicine: The Future is Now. Cancun, Mexico: 5-8 May 2002
pp. 33-35(3)
Author: listed n.

12th International Conference On Pharmaceutical Medicine: The Future is Now. Cancun, Mexico: 5-8 May 2002
pp. 35-36(2)
Author: listed n.

12th International Conference On Pharmaceutical Medicine: The Future is Now. Cancun, Mexico: 5-8 May 2002
pp. 36-41(6)
Author: listed n.

Message from Dr Johanna Schenk, retiring President of IFAPP
pp. 43-44(2)
Author: SCHENK J.

Letter from Dr Domenico Criscuolo, incoming President of IFAPP
pp. 44-45(2)
Author: CRISCUOLO D.

News from member associations
pp. 45-49(5)
Author: listed n.

Fifth EMEA/IFAPP Conference. Meeting report: Clinical studies at the extremes of age
pp. 49-56(8)
Author: Robert S.

Department of Pharmaceutical Medicine
pp. 57-57(1)
Author: listed n.

Pharmacovigilance from A to Z: Adverse drug event surveillance
pp. 59-59(1)
Author: Brown E.

Erratum
pp. 61-61(1)
Author: listed n.